Codexis, Inc. is a developer of biocatalysts. The Company is engaged in the pharmaceutical and fine chemical industries. The Company's CodeEvolver protein engineering technology platform is used in the evolution and optimization of biocatalysts to perform specific and desired chemical reactions at commercial scale. The pharmaceutical customers use its technology, products and services in their manufacturing process development and production of drugs. The Company's technologies enable scale-up and implementation of biocatalytic solutions for sustainable process development, from research to manufacturing. The Company's products include Codex screening panels and kits that enable customers to establish optimal reactions. The Company's pharmaceutical products include enzymes, pharmaceutical intermediates and Codex Biocatalyst Kits and Panels.